✦ LIBER ✦

Methodological aspects of current problems in target-based anticancer drug development

✍ Scribed by Takeharu Yamanaka; Tatsuro Okamoto; Yukito Ichinose; Shinya Oda; Yoshihiko Maehara

Publisher: Springer
Year: 2006
Tongue: English
Weight: 273 KB
Volume: 11
Category: Article
ISSN: 1341-9625
DOI: 10.1007/s10147-006-0580-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Current challenges for the early clinica

Current challenges for the early clinical development of anticancer drugs in the era of molecularly targeted agents

✍ Christophe Le Tourneau; Véronique Diéras; Patricia Tresca; Wulfran Cacheux; Xavi 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 148 KB

ChemInform Abstract: Development of New

ChemInform Abstract: Development of New Anticancer Drugs — The Historical Background and Current Status in Japan

✍ S. TSUKAGOSHI 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 25 KB 👁 1 views

Gastric cancer in the era of molecularly

Gastric cancer in the era of molecularly targeted agents: current drug development strategies

✍ Hendrik-Tobias Arkenau 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 399 KB

Advances in molecular carcinogenesis: cu

Advances in molecular carcinogenesis: current and future use of mouse models to screen and validate molecularly targeted anticancer drugs

✍ Anita F.W. Frijhoff; Claudio J. Conti; Adrian M. Senderowicz 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB

## Abstract Survival of patients with advanced solid tumors has not significantly improved over the past 30 years. Although molecularly targeted anticancer drugs offer promise, few drugs make it through the end of the Food and Drug Administration approval process. Animal models that more closely re

Development of an evidence-based checkli

Development of an evidence-based checklist for the detection of drug related problems in type 2 diabetes

✍ Roozendaal, Bob W. ;Krass, Ines 📂 Article 📅 2009 🏛 Springer 🌐 Dutch ⚖ 548 KB